Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients

A great disappointment in head and neck cancer surgery is that 10–30% of head and neck squamous cell carcinoma (HNSCC) patients develop local recurrences despite histopathologically tumor-free surgical margins. These recurrences result from either minimal residual cancer (MRC) or preneoplastic lesio...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Peggy Graveland, Michiel de Maaker, Boudewijn J. M. Braakhuis, Remco de Bree, Simone E. J. Eerenstein, Elisabeth Bloemena, C. René Leemans, Ruud H. Brakenhoff
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.3233/CLO-2009-0474
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563947612405760
author A. Peggy Graveland
Michiel de Maaker
Boudewijn J. M. Braakhuis
Remco de Bree
Simone E. J. Eerenstein
Elisabeth Bloemena
C. René Leemans
Ruud H. Brakenhoff
author_facet A. Peggy Graveland
Michiel de Maaker
Boudewijn J. M. Braakhuis
Remco de Bree
Simone E. J. Eerenstein
Elisabeth Bloemena
C. René Leemans
Ruud H. Brakenhoff
author_sort A. Peggy Graveland
collection DOAJ
description A great disappointment in head and neck cancer surgery is that 10–30% of head and neck squamous cell carcinoma (HNSCC) patients develop local recurrences despite histopathologically tumor-free surgical margins. These recurrences result from either minimal residual cancer (MRC) or preneoplastic lesions that remain behind after tumor resection. Distinguishing MRC from preneoplasic lesions is important to tailor postoperative radiotherapy more adequately. Here we investigated the suitability of quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) using human Ly-6D (hLy-6D) transcripts as molecular marker to detect MRC in surgical margins.
format Article
id doaj-art-e20bc508bf6b4c31bce1690884501b5d
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-e20bc508bf6b4c31bce1690884501b5d2025-02-03T01:12:16ZengWileyCellular Oncology1570-58701875-86062009-01-0131431732810.3233/CLO-2009-0474Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer PatientsA. Peggy Graveland0Michiel de Maaker1Boudewijn J. M. Braakhuis2Remco de Bree3Simone E. J. Eerenstein4Elisabeth Bloemena5C. René Leemans6Ruud H. Brakenhoff7Department of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Pathology, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The NetherlandsA great disappointment in head and neck cancer surgery is that 10–30% of head and neck squamous cell carcinoma (HNSCC) patients develop local recurrences despite histopathologically tumor-free surgical margins. These recurrences result from either minimal residual cancer (MRC) or preneoplastic lesions that remain behind after tumor resection. Distinguishing MRC from preneoplasic lesions is important to tailor postoperative radiotherapy more adequately. Here we investigated the suitability of quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) using human Ly-6D (hLy-6D) transcripts as molecular marker to detect MRC in surgical margins.http://dx.doi.org/10.3233/CLO-2009-0474
spellingShingle A. Peggy Graveland
Michiel de Maaker
Boudewijn J. M. Braakhuis
Remco de Bree
Simone E. J. Eerenstein
Elisabeth Bloemena
C. René Leemans
Ruud H. Brakenhoff
Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients
Cellular Oncology
title Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients
title_full Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients
title_fullStr Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients
title_full_unstemmed Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients
title_short Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients
title_sort molecular detection of minimal residual cancer in surgical margins of head and neck cancer patients
url http://dx.doi.org/10.3233/CLO-2009-0474
work_keys_str_mv AT apeggygraveland moleculardetectionofminimalresidualcancerinsurgicalmarginsofheadandneckcancerpatients
AT michieldemaaker moleculardetectionofminimalresidualcancerinsurgicalmarginsofheadandneckcancerpatients
AT boudewijnjmbraakhuis moleculardetectionofminimalresidualcancerinsurgicalmarginsofheadandneckcancerpatients
AT remcodebree moleculardetectionofminimalresidualcancerinsurgicalmarginsofheadandneckcancerpatients
AT simoneejeerenstein moleculardetectionofminimalresidualcancerinsurgicalmarginsofheadandneckcancerpatients
AT elisabethbloemena moleculardetectionofminimalresidualcancerinsurgicalmarginsofheadandneckcancerpatients
AT creneleemans moleculardetectionofminimalresidualcancerinsurgicalmarginsofheadandneckcancerpatients
AT ruudhbrakenhoff moleculardetectionofminimalresidualcancerinsurgicalmarginsofheadandneckcancerpatients